BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 23842730)

  • 1. Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes.
    Nesca V; Guay C; Jacovetti C; Menoud V; Peyot ML; Laybutt DR; Prentki M; Regazzi R
    Diabetologia; 2013 Oct; 56(10):2203-12. PubMed ID: 23842730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microRNAs in the age-associated decline of pancreatic beta cell function in rat islets.
    Tugay K; Guay C; Marques AC; Allagnat F; Locke JM; Harries LW; Rutter GA; Regazzi R
    Diabetologia; 2016 Jan; 59(1):161-169. PubMed ID: 26474776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNAs as novel regulators of β-cell functions in normal and disease conditions.
    Stoll L; Sobel J; Rodriguez-Trejo A; Guay C; Lee K; Venø MT; Kjems J; Laybutt DR; Regazzi R
    Mol Metab; 2018 Mar; 9():69-83. PubMed ID: 29396373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV8-mediated gene transfer of microRNA-132 improves beta cell function in mice fed a high-fat diet.
    Mulder NL; Havinga R; Kluiver J; Groen AK; Kruit JK
    J Endocrinol; 2019 Feb; 240(2):123-132. PubMed ID: 30400037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of miR-153, an IL-1β-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes.
    Sun Y; Zhou S; Shi Y; Zhou Y; Zhang Y; Liu K; Zhu Y; Han X
    Metabolism; 2020 Oct; 111():154335. PubMed ID: 32795559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-146a, miR-34a and miR-375 in type 2 diabetes patients, pre-diabetic and normal-glycaemic individuals in relation to β-cell function, insulin resistance and metabolic parameters.
    García-Jacobo RE; Uresti-Rivera EE; Portales-Pérez DP; González-Amaro R; Lara-Ramírez EE; Enciso-Moreno JA; García-Hernández MH
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1092-1100. PubMed ID: 31355469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletion of miR-204 improves glycemic control despite obesity in db/db mice.
    Gaddam RR; Kim YR; Li Q; Jacobs JS; Gabani M; Mishra A; Promes JA; Imai Y; Irani K; Vikram A
    Biochem Biophys Res Commun; 2020 Nov; 532(2):167-172. PubMed ID: 32950230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.
    Roggli E; Britan A; Gattesco S; Lin-Marq N; Abderrahmani A; Meda P; Regazzi R
    Diabetes; 2010 Apr; 59(4):978-86. PubMed ID: 20086228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion.
    Sebastiani G; Po A; Miele E; Ventriglia G; Ceccarelli E; Bugliani M; Marselli L; Marchetti P; Gulino A; Ferretti E; Dotta F
    Acta Diabetol; 2015 Jun; 52(3):523-30. PubMed ID: 25408296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic β- and α-Cells.
    Mohan R; Mao Y; Zhang S; Zhang YW; Xu CR; Gradwohl G; Tang X
    J Biol Chem; 2015 Aug; 290(32):19955-66. PubMed ID: 26109062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell.
    Ofori JK; Salunkhe VA; Bagge A; Vishnu N; Nagao M; Mulder H; Wollheim CB; Eliasson L; Esguerra JL
    Sci Rep; 2017 Mar; 7():44986. PubMed ID: 28332581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microRNA-29 Family Dictates the Balance Between Homeostatic and Pathological Glucose Handling in Diabetes and Obesity.
    Dooley J; Garcia-Perez JE; Sreenivasan J; Schlenner SM; Vangoitsenhoven R; Papadopoulou AS; Tian L; Schonefeldt S; Serneels L; Deroose C; Staats KA; Van der Schueren B; De Strooper B; McGuinness OP; Mathieu C; Liston A
    Diabetes; 2016 Jan; 65(1):53-61. PubMed ID: 26696639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-34a-5p and miR-452-5p: The Novel Regulators of Pancreatic Endocrine Dysfunction in Diabetic Zucker Rats?
    Su T; Hou J; Liu T; Dai P; Qin L; Ding L; Hu Y; Guo X
    Int J Med Sci; 2021; 18(14):3171-3181. PubMed ID: 34400887
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of islet-enriched long non-coding RNAs contributing to β-cell failure in type 2 diabetes.
    Motterle A; Gattesco S; Peyot ML; Esguerra JLS; Gomez-Ruiz A; Laybutt DR; Gilon P; Burdet F; Ibberson M; Eliasson L; Prentki M; Regazzi R
    Mol Metab; 2017 Nov; 6(11):1407-1418. PubMed ID: 29107288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Intronic miR-338-3p and Its Hosting Gene AATK to Compensatory β-Cell Mass Expansion.
    Jacovetti C; Jimenez V; Ayuso E; Laybutt R; Peyot ML; Prentki M; Bosch F; Regazzi R
    Mol Endocrinol; 2015 May; 29(5):693-702. PubMed ID: 25751313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
    Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
    Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
    [No Abstract]   [Full Text] [Related]  

  • 18. MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells.
    Sebastiani G; Valentini M; Grieco GE; Ventriglia G; Nigi L; Mancarella F; Pellegrini S; Martino G; Sordi V; Piemonti L; Dotta F
    Acta Diabetol; 2017 Mar; 54(3):265-281. PubMed ID: 28039581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated circulating stearic acid leads to a major lipotoxic effect on mouse pancreatic beta cells in hyperlipidaemia via a miR-34a-5p-mediated PERK/p53-dependent pathway.
    Lu H; Hao L; Li S; Lin S; Lv L; Chen Y; Cui H; Zi T; Chu X; Na L; Sun C
    Diabetologia; 2016 Jun; 59(6):1247-57. PubMed ID: 26969487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRP78 overproduction in pancreatic beta cells protects against high-fat-diet-induced diabetes in mice.
    Teodoro-Morrison T; Schuiki I; Zhang L; Belsham DD; Volchuk A
    Diabetologia; 2013 May; 56(5):1057-67. PubMed ID: 23475366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.